amifostine anhydrous has been researched along with Condition, Preneoplastic in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manola, KN | 1 |
| Terzoudi, GI | 1 |
| Dardoufas, CE | 1 |
| Malik, SI | 1 |
| Pantelias, GE | 1 |
1 other study available for amifostine anhydrous and Condition, Preneoplastic
| Article | Year |
|---|---|
Radioprotective effect of amifostine on cells from cancer prone patients and healthy individuals studied by the G2 and PCC assays.
Topics: Amifostine; Ataxia Telangiectasia; Cell Line, Tumor; Chromosome Aberrations; Cytogenetic Analysis; G | 2003 |